Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells

• David J. Panka,
• Qingjun Liu,
• Andrew K. Geissler,
• James W. Mier

Affiliations

David J. Panka

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School

Qingjun Liu

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School

Andrew K. Geissler

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School

James W. Mier

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School